Health
New drug reduces tumor volume and pain in patients with neurofibromatosis type 1 – News-Medical.Net
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP) as part of the…
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP) as part of the Neurofibromatosis Clinical Trials Consortium have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1).
The results of the Phase 2 clinical trial, co-chaired by Michael J. Fisher, MD at CHOP, were published recently in Nature Medicine.
“This is the second…
-
General19 hours agoTributes flow after Australian Paralympic bronze medallist Nicholas Hum dies aged 32
-
General14 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
General15 hours agoNT’s top year 12 achievers celebrated, with some looking to pursue teaching careers
-
Noosa News14 hours agoUpdate: Attempted murder charges, Maroochydore